Method and system for preventing sore throat in humans
A method and system to prevent sore throat infections in humans includes the administration of an active ingredient to a site on the mucus membranes of the throat of a human that inhibits adherence and promotes desorption of S. pyogenes to soft tissue surfaces, such as the pharyngeal and oral mucosa of a human. A mucoadhesive strip having a surface topography that resists bioadhesion of undesired bacteria that are typically present in a human's mouth is preferably employed and that has one or more encapsulated agents selected from the group consisting of an antibiotic; lactic acid bacteria; S. pyogenes modified by a CRISPR-Cas system to reduce one or more virulence factors; and a breath mint solution.
1. A bioadhesive strip for treating sore throat in a human being, comprising: a solid strip having a first and second side, said first side having a bioadhesive that is adapted to bind to a mucosal membrane for at least 1 hour while inside a person's mouth, wherein said strip is sized to extend over a majority of the soft palate, and wherein said strip includes one of an analgesic, and a lactic acid bacteria that coaggregates with Streptococcus pyogenes , and wherein a clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein (Cas) system or a CRISPR from Prevotella and Francisella 1 (Cpf1) system is employed to silence or to delete at least one virulence factor of S. pyogenes.
2. The strip of claim 1 , wherein said strip includes at least one polymer selected from the group consisting of pullulan, hydroxypropylmethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl pyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium alginate, polyethylene glycol, tragacanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, methylmethacrylate copolymer, carboxyvinyl polymer, amylose, high amylose starch, hydroxypropylated high amylose starch, dextrin, pectin, chitin, chitosan, levan, elsinan, collagen, gelatin, zein, gluten, soy protein isolate, whey protein isolate, casein and mixtures thereof.
3. The strip of claim 1 wherein said strip has an analgesic encapsulated inside a frangible capsule that may be broken by a person pressing against said strip with the person's tongue.
4. The strip of claim 1 wherein said strip is dissolvable in a person's mouth within a period of 3 hours.
5. The strip of claim 1 , wherein said strip further includes at least 200 mg of xylitol.
6. The strip as set forth in claim 1 , wherein said strip comprises Prevotella bacteria.
7. The strip of claim 1 , wherein the strip comprises lactic acid bacteria are specifically able to coaggregate with S. pyogenes.
8. A bioadhesive strip for treating sore throat in a human being, comprising: a solid strip having a first and second side, wherein said strip is sized to extend over a majority of the soft palate, said first side having at least one encapsulated feature containing at least one bacteria transformed by a clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein (Cas) system or a CRISPR from Prevotella and Francisella 1 (Cpf1) system to render said bacteria sensitized to an antibiotic, and said second side having a bioadhesive that is adapted to bind to a mucosal membrane for at least 1 hour while inside a person's mouth.
9. The strip as set forth in claim 8 , wherein said at least one bacteria has one of a pathogenic or toxic element excised using a clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein (Cas) system or a CRISPR from Prevotella and Francisella 1 (Cpf1) system.
10. The strip as set forth in claim 8 , wherein said at least one bacteria is modified by employment of a CRISPR-Cas or a Cpf1 system to reduce the expression of an endogenous pathogenic protein.
11. The strip of claim 8 wherein said strip has an analgesic encapsulated inside a frangible capsule that may be broken by a person pressing against said strip with the person's tongue.
12. The strip of claim 8 , wherein said strip further includes at least 200 mg of xylitol.
13. The strip as set forth in claim 8 , wherein said strip comprises Prevotella bacteria.
14. A bioadhesive solid strip for treating sore throat in a human being, comprising: a strip having a first and second side, the first side having a bioadhesive that is adapted to bind to a mucosal membrane for at least 1 hour while inside a person's mouth, said strip having a length dimension of between 0.5 and 2 cm; a surface area of 0.25-1.5 inches; and a weight of at least 30 mg, said strip including Streptococcus pyogenes modified by a clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein (Cas) system to reduce one or more virulence factors.
15. The strip of claim 14 , wherein the strip comprises S. pyogenes that have been modified to render ineffective virulence factors in a manner effective to avoid sore throat progression.
16. The strip of claim 14 , wherein the strip comprises lactic acid bacteria that are specifically able to coaggregate with S. pyogenes.
17. The strip of claim 14 , wherein the strip comprises S. pyogenes that have been modified to remove or disable one or more virulence factors and wherein the S. pyogenes is encapsulated on the strip within a pouch or pocket.
18. The strip of claim 14 , wherein the strip further includes at least 200 mg of xylitol.
19. The strip of claim 14 , wherein said strip reduces the adhesion of S. pyogenes to an epithelial tissue of a person.
20. The strip of claim 14 , wherein the strip has a thickness of between 100-400 microns thick and includes helminth components.